Pharmaceutical and pharmacological approaches for bioavailability enhancement of etoposide
- 1 February 2014
- journal article
- review article
- Published by Springer Nature in Journal of Biosciences
- Vol. 39 (1) , 139-144
Abstract
Etoposide, a semi-synthetic derivative of podophyllotoxin, is one of the most active and useful antineoplastic agent used routinely in firstline combination chemotherapy of testicular cancer, small-cell lung cancer and non-Hodgkin’s lymphoma. Etoposide displays narrow therapeutic index, erratic pharmacokinetics and dose individualization that needs to be achieved for overcoming inter- and intra-patient variability (25–80%), so as to maintain proper drug exposure within a therapeutic range. Etoposide posses high plasma protein binding (97%) and is degraded via complex metabolic pathways. The main pharmacokinetic determinants of etoposide are still not completely defined in order to optimize the pharmaco-therapeutic parameters including dose, therapeutic schedule and route of administration. Much research has been done to determine drug–drug and herb–drug interactions for improving the bioavailability of etoposide. The present article gives insight on pharmaceutical and pharmacological attempts made from time to time to overcome the erratic inter- and intra-patient variability for improving the bioavailability of etoposide.Keywords
This publication has 55 references indexed in Scilit:
- pH-sensitive strontium carbonate nanoparticles as new anticancer vehicles for controlled etoposide releaseInternational Journal of Nanomedicine, 2012
- Optimization of self-assembling properties of fatty acids grafted to methoxy poly(ethylene glycol) as nanocarriers for etoposideActa Pharmaceutica, 2012
- Laminin receptor-targeted etoposide loaded polymeric micelles: a novel approach for the effective treatment of tumor metastasisJournal of Drug Targeting, 2011
- Involvement of P-glycoprotein and CYP 3A4 in the enhancement of etoposide bioavailability by a piperine analogueChemico-Biological Interactions, 2011
- Formulation Development of Parenteral Phospholipid-based Microemulsion of EtoposideAAPS PharmSciTech, 2010
- Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugsJournal of Controlled Release, 2009
- Synthesis and Characterization of Star Poly(ε-caprolactone)-b-Poly(ethylene glycol) and Poly(l-lactide)-b-Poly(ethylene glycol) Copolymers: Evaluation as Drug Delivery CarriersBioconjugate Chemistry, 2008
- Etoposide Induces ATM-Dependent Mitochondrial Biogenesis through AMPK ActivationPLOS ONE, 2008
- Etoposide Loaded PLGA and PCL Nanoparticles II: Biodistribution and Pharmacokinetics after Radiolabeling with Tc-99mDrug Delivery, 2008
- Camptothecin and Podophyllotoxin DerivativesDrug Safety, 2006